Nephros (NEPH) Liabilities and Shareholders Equity (2016 - 2025)
Historic Liabilities and Shareholders Equity for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to $13.2 million.
- Nephros' Liabilities and Shareholders Equity rose 2754.67% to $13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $48.5 million, marking a year-over-year increase of 829.93%. This contributed to the annual value of $11.2 million for FY2024, which is 548.86% down from last year.
- Nephros' Liabilities and Shareholders Equity amounted to $13.2 million in Q3 2025, which was up 2754.67% from $12.2 million recorded in Q2 2025.
- In the past 5 years, Nephros' Liabilities and Shareholders Equity ranged from a high of $18.0 million in Q2 2021 and a low of $10.4 million during Q2 2023
- Its 5-year average for Liabilities and Shareholders Equity is $13.1 million, with a median of $11.8 million in 2025.
- In the last 5 years, Nephros' Liabilities and Shareholders Equity crashed by 3768.27% in 2022 and then soared by 2754.67% in 2025.
- Over the past 5 years, Nephros' Liabilities and Shareholders Equity (Quarter) stood at $17.6 million in 2021, then tumbled by 37.68% to $11.0 million in 2022, then grew by 7.84% to $11.9 million in 2023, then decreased by 5.49% to $11.2 million in 2024, then grew by 18.17% to $13.2 million in 2025.
- Its last three reported values are $13.2 million in Q3 2025, $12.2 million for Q2 2025, and $11.8 million during Q1 2025.